Literature DB >> 2620956

Adrenocortical involvement in aluminium phosphide poisoning.

S N Chugh, S Ram, A Sharma, B B Arora, A S Saini, K C Malhotra.   

Abstract

The effect of aluminium phosphide (AlP) which is a systemic poison on the adrenal cortex was studied in 30 patients of AlP poisoning. A significant rise in the plasma cortisol level (greater than 1048 nmol/l) was observed in the twenty patients. Mortality was 50 per cent. Autopsy study could be undertaken only in 10 patients. Histopathology showed mild to moderate changes. In the rest (10 patients), the adrenal cortex was critically involved and the cortisol level failed to rise beyond normal levels (less than 690 nmol/l). The histopathology revealed severe changes (complete lipid depletion, haemorrhage, necrosis etc.) and all these patients died. In the critically ill patients, the cortisol levels remained low because of severe adreno-cortical involvement. The changes in the adrenal cortex could be due to shock or to cellular toxic effect of phosphine. The histopathological changes in various viscera showed congestion, edema and cellular infiltration. In the heart, there were patchy areas of necrosis, while the liver showed fatty changes and the lungs showed, in addition areas of gray/red hepatization. There was no adrenal apoplexy or extensive haemorrhage that could explain shock in these patients. Cardiogenic shock could not be confirmed due to lack of facilities for haemodynamic monitoring, but there was histopathological evidence in support of cardiovascular shock.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2620956

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  11 in total

1.  Lethal heart failure caused by aluminium phosphide poisoning.

Authors:  P Alter; W Grimm; B Maisch
Journal:  Intensive Care Med       Date:  2001-01       Impact factor: 17.440

2.  Prognostic value of cortisol and thyroid function tests in poisoned patients admitted to toxicology ICU.

Authors:  Shahin Shadnia; Nasim Zamani; Hossein Hassanian-Moghaddam; Hamed Shafaroodi; Mina Padandar; Mohammad Hasan Rezaeizadeh
Journal:  World J Emerg Med       Date:  2018

3.  Managing aluminum phosphide poisonings.

Authors:  Mohan Gurjar; Arvind K Baronia; Afzal Azim; Kalpana Sharma
Journal:  J Emerg Trauma Shock       Date:  2011-07

4.  Fatal aluminium phosphide poisoning.

Authors:  Mahesh Chand Meena; Sachin Mittal; Yashoda Rani
Journal:  Interdiscip Toxicol       Date:  2015-06

5.  Pulmonary Management in Aluminum Phosphide Poisoning.

Authors:  Ashok Kumar Pannu
Journal:  Indian J Crit Care Med       Date:  2017-01

6.  Clinical characteristics of zinc phosphide poisoning in Thailand.

Authors:  Satariya Trakulsrichai; Natcha Kosanyawat; Pongsakorn Atiksawedparit; Charuwan Sriapha; Achara Tongpoo; Umaporn Udomsubpayakul; Panee Rittilert; Winai Wananukul
Journal:  Ther Clin Risk Manag       Date:  2017-03-14       Impact factor: 2.423

7.  Mercury in the human adrenal medulla could contribute to increased plasma noradrenaline in aging.

Authors:  Roger Pamphlett; Stephen Kum Jew; Philip A Doble; David P Bishop
Journal:  Sci Rep       Date:  2021-02-03       Impact factor: 4.379

8.  Prognostic Significance of Blood Glucose Levels and Alterations Among Patients with Aluminium Phosphide Poisoning.

Authors:  Arvind Sharma; Prasanth Balasubramanian; Kiran D Gill; Ashish Bhalla
Journal:  Sultan Qaboos Univ Med J       Date:  2018-12-19

9.  An update on toxicology of aluminum phosphide.

Authors:  Ali Akbar Moghadamnia
Journal:  Daru       Date:  2012-09-03       Impact factor: 3.117

10.  Comment on "An update on toxicology of aluminum phosphide".

Authors:  Omid Mehrpour
Journal:  Daru       Date:  2012-10-08       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.